ARCHIVES

DCPC Advisors Commit $32 Mil. To Chemoprevention

This article is from The Cancer Letter archive.

Vol. 17 No. 23 | June 7, 1991

Download PDF Visit The Full Archive

Related Articles

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

April 5, 2002

Money Earmarked for WVU Center Could Be Returned To Treasury; BYRD Get Assurances From DeVita

May 31, 1985

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

Abstracts From AACR Annual Meeting

May 28, 1976